Nautilus Biotechnology, Inc. (NAUT): 7 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Mar 4, 2026 | Patel Sujal M Director, Officer, TenPercentOwner | 25,000 | $2.61 | $65.2K | no history |
| Nov 10, 2025 | Suzuki Kentaro Officer | 4,000 | $1.49 | $6.0K | no history |
| Sep 9, 2025 | Patel Sujal M Director, Officer, TenPercentOwner | 200,000 | $0.67 | $134.8K | no history |
| Sep 5, 2025 | Murphy Matthew B. Officer | 20,000 | $0.64 | $12.8K | no history |
| Jun 2, 2025 | Mowry Anna Officer | 15,000 | $0.77 | $11.6K | no history |
| May 12, 2025 | Mallick Parag Director, Officer, TenPercentOwner | 13,500 | $0.73 | $9.9K | no history |
| Mar 21, 2025 | Patel Sujal M Director, Officer, TenPercentOwner | 77,233 | $0.99 | $76.7K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.